Atsena Therapeutics
atsenatx.comLocations
Durham, NC, USA · Boston, MA, USA · Duke University - Main Campus, Durham, NC, USA
founded in
2019
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases. Their clinical programs include therapies for X-linked retinoschisis (XLRS) and GUCY2D-associated Leber congenital amaurosis (LCA1). Atsena utilizes an adeno-associated virus (AAV) technology platform, including a novel spreading capsid (AAV.SPR), to target specific retinal conditions. Their ongoing research aims to prevent blindness caused by genetic mutations and is powered by their innovative approach to ocular gene therapy.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the North Carolina Biotechnology Center network.
Something looks off?
Open jobs at Atsena Therapeutics
On-site & Remote
Job function
Seniority
Salary